{
  "url": "https://openlegislation.uk/eu-regulation-1997-749/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-1997-749/annex.json",
  "legislation": "eur/1997/749",
  "legislation_title": "Commission Regulation (EC) No 749/97 of 25 April 1997 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin",
  "legislation_url": "https://openlegislation.uk/eu-regulation-1997-749",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "The Annexes to Regulation (EEC) No 2377/90 are amended as follows:\nA.. Annex I is amended as follows:\n1.. Anti-infectious agents\n1.2. Antibiotics\n1.2.3. Quinolones\nPharmacologically active substance\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n‘1.2.3.3.\nDifloxacin\nDifloxacin\nChicken, turkey\n1 900 μg/kg\nLiver\n600 μg/kg\nKidney\n300 μg/kg\nMuscle\n400 μg/kg\nSkin/fat’\n4.. Anti-inflammatory agents\n4.1. Nonsteroidal anti-inflammatory agents\n4.1.1. Arylpropionic acid derivative\nPharmacologically active substance\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n‘4.1.1.1.\nVedaprofen\nVedaprofen\nEquidae\n1 000 μg/kg\nKidney\n100 μg/kg\nLiver\n50 μg/kg\nMuscle\n20 μg/kg\nFat’\nB.. Annex II is amended as follows:\n2.. Organic compounds\nPharmacologically active substance(s)\nAnimal species\nOther provisions\n‘2.82.\nThiomersal\nAll food producing species\nFor use only as preservatives in multidose vaccines at a concentration not exceeding 0,02 %\n2.83.\nTimerfonate\nAll food producing species\nFor use only as preservatives in multidose vaccines at a concentration not exceeding 0,02 %’\nC.. Annex III is amended as follows:\n1.. Anti-infectious agents\n1.2. Antibiotics\n1.2.10. Beta-lactamase inhibitors\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n‘1.2.10.1.\nClavulanic acid\nClavulanic acid\nBovine, ovine, porcine\n200 μg/kg\nMuscle, liver, kidney, fat\nProvisional MRLs expire on 1. 7. 1999’\nBovine, ovine\n200 μg/kg\nMilk\n4.. Corticoids\n4.1. Glucocorticoids\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n‘4.1.1.\nexamethasone\nDexamethasone\nBovine, porcine, equidae\n2,5 μg/kg\nLiver\nProvisional MRLs expire on 1. 7. 1997’\n0,5 μg/kg\nMuscle, kidney\nBovine\n0,3 μg/kg\nMilk",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/1997/749/annex",
    "retrieved_at": "2026-11-01T14:58:48.650768+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}